Sunshine Biopharma's market cap is currently $6.70M. The company's EPS TTM is $-0.394; its P/E ratio is ―; Sunshine Biopharma is scheduled to report earnings on July 30, 2025, and the estimated EPS forecast is $-0.09. See an overview of income statement, balance sheet, and cash flow financials.
